Formidable Asset Management LLC Trims Position in Chemed Corporation $CHE

Formidable Asset Management LLC cut its stake in shares of Chemed Corporation (NYSE:CHE) by 17.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,781 shares of the company’s stock after selling 3,487 shares during the period. Chemed accounts for approximately 1.1% of Formidable Asset Management LLC’s portfolio, making the stock its 16th largest holding. Formidable Asset Management LLC owned approximately 0.12% of Chemed worth $7,487,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CHE. JPMorgan Chase & Co. grew its stake in Chemed by 122.7% during the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock valued at $223,856,000 after acquiring an additional 275,423 shares in the last quarter. Norges Bank purchased a new stake in Chemed in the 2nd quarter worth approximately $89,388,000. AQR Capital Management LLC lifted its stake in Chemed by 160.9% in the 2nd quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock worth $97,893,000 after purchasing an additional 123,982 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in Chemed by 740.9% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 95,573 shares of the company’s stock valued at $42,792,000 after purchasing an additional 84,208 shares during the period. Finally, Epoch Investment Partners Inc. boosted its holdings in Chemed by 29.4% in the 3rd quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock valued at $137,579,000 after purchasing an additional 69,878 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Oppenheimer decreased their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, January 22nd. Zacks Research cut Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, January 21st. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Chemed has an average rating of “Hold” and an average target price of $498.00.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the completion of the transaction, the chief executive officer directly owned 93,719 shares in the company, valued at approximately $37,785,626.42. This represents a 2.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.29% of the stock is currently owned by company insiders.

Chemed Price Performance

Shares of NYSE:CHE opened at $380.46 on Friday. The company’s fifty day moving average price is $422.33 and its 200-day moving average price is $433.38. The firm has a market capitalization of $5.24 billion, a price-to-earnings ratio of 20.71, a PEG ratio of 1.50 and a beta of 0.49. Chemed Corporation has a one year low of $365.20 and a one year high of $623.60.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a net margin of 10.48% and a return on equity of 25.66%. The company had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. During the same quarter last year, the business posted $6.83 EPS. The business’s quarterly revenue was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, equities research analysts expect that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s payout ratio is 13.06%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.